Robust methods enabling distributed biomanufacturing of essential medicines via synthetic biology.
open
Costa Rica, North America
WS03131
Despite recognition of its importance, reliable methods for distributed biomanufacturing of essential medicines via synthetic biology are still lacking. Progress is hindered by incomplete mechanistic knowledge, high capital and operational barriers, and the absence of deployment models suited to the contexts of greatest need.